Related Experiment Video
Updated: Jun 17, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
The Pathogenesis of Type 1 Diabetes.
Kevan C Herold1, Jeffrey P Krischer2
1Departments of Immunobiology and Internal Medicine, Yale University, New Haven, Connecticut 06519, USA Kevan.herold@yale.edu.
Type 1 diabetes (T1D) is an autoimmune disease. Early interventions, like teplizumab, can now delay T1D diagnosis by targeting immune responses.
Area of Science:
- Immunology
- Endocrinology
- Autoimmune Diseases
Background:
- Type 1 diabetes (T1D) is a chronic autoimmune condition characterized by beta-cell destruction.
- Genetic predisposition and environmental factors contribute to T1D pathogenesis.
- Increasing T1D incidence may be linked to reduced infection exposure (hygiene hypothesis).
Purpose of the Study:
- To review the stages of T1D progression.
- To discuss the role of immunologic and metabolic markers in disease staging.
- To highlight therapeutic interventions for modulating T1D progression.
Main Methods:
- Review of existing literature on T1D pathogenesis and progression.
- Analysis of immunologic markers (autoantibodies) and metabolic markers (glucose tolerance).
- Examination of therapeutic strategies targeting T1D development.
Main Results:
- T1D progresses through defined stages based on immune and metabolic markers.
- Current staging methods offer a general risk assessment but lack precision in predicting diagnosis time and disease activity.
- Teplizumab, an anti-CD3 monoclonal antibody, is approved for delaying T1D diagnosis.
Conclusions:
- Understanding T1D progression stages aids in identifying at-risk individuals.
- Interventions like teplizumab offer a new approach to modulate T1D onset.
- Further research is needed to refine staging and develop more targeted therapies.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

